Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosneft consolidated 100% of the shipping company Prime Shipping

2/12/24 ROSN

Alrosa expects to discover new ore bodies

2/12/24 ALRS

RBT conducted preclinical studies of a new immunomodulator

2/12/24 ABIO

Yandex Lavka launched a brand of selective products

2/12/24 YNDX

Etalon's sales in January increased 4 times

2/12/24 ETLN

VK acquires 70% in RuStore developer

2/12/24 VKCO

TCS Group has created an investment platform

2/9/24 T

Member of the board of directors of Cian Mikhail Zhukov has died

2/9/24 CIAN

HeadHunter President Mikhail Zhukov has died

2/9/24 HEAD

Nornickel reported for 2023 by RAS

2/9/24 GMKN